Amedisys, Inc. (AMED) Tops Q3 EPS by 6c

Amedisys, Inc. (NASDAQ: AMED) reported Q3 EPS of $0.33, $0.06 better than the analyst estimate of $0.27. Revenue for the quarter came in at $375.63 million versus the consensus estimate of $379.97 million.

For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• IP Strategy reports June validator results with 200,651 $DATA tokens earned
• Jefferies Upgrades Yihai International Holding Ltd. (1579:HK) (YNNHF) to Buy